Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| B4Development Foundation (Supreme Committee for Delivery and Legacy) | UNKNOWN |
| Nudge Lebanon | UNKNOWN |
| University of Warwick | OTHER |
Not provided
Not provided
Not provided
Not provided
The study had two stages. Stage 1 involved an opportunistic screening for hypertension conducted at the 2018 Beirut Marathon. During stage 1, participants whose measurements indicated hypertension were invited to take part in a RCT (randomized controlled trial). Stage 2 involved a RCT to evaluate the effectiveness of a behavioural intervention to increase the proportion of participants who sought further medical attention. The research team hypothesised that the intervention would increase the proportion of participants who sought further medical attention compared to a control group that did not receive the intervention.
This is a retrospective registration specifically focused on the RCT component of this study. The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were unaware that pre-registration would be necessary. The collaborators asked the University of Warwick to re-analyse and write the project up for publication after the study was complete. The University of Warwick is now seeking to retrospectively register the trial before submitting to an academic journal. The fact that this trial is retrospectively registered will be plainly stated in the manuscript and all analyses will be presented as exploratory.
This study had two stages. Stage 1 involved an opportunistic screening and Stage 2 involved in RCT. This registration focuses on the RCT but both stages are described here.
Stage 1. The opportunistic screening for hypertension was conducted around the 2018 Beirut Marathon. Screening tents were set up at the marathon village during the four days leading up to the marathon (7-10 November), where runners collected necessary materials for the run and could take up the screening. An additional two tents were set up during the marathon day were spectators could take part. Participants indicated their consent for the screening before taking part. During their participation they completed surveys about their demographics and health information (including whether they were hypertensive). After they completed the survey, nurses and trained team members measured their blood pressure using calibrated equipment. Those participants whose measurements indicated hypertension were invited to participate in the RCT.
Stage 2. For the RCT participants were randomly assigned to either a intervention or control group in a 1:1 fashion. Participants in the intervention group were sent a WhatsApp message 25 days after the marathon reminding them to seek help for their hypertensive condition. Participants in the control group were not sent this message. Then one month later the researchers called all these participants to ask wither they sought further medical attention. The main outcome was whether participants self-reported seeking further medical attention.
The research objectives were as follows:
Stage 1 screening: Evaluate if the opportunistic screening increased people's awareness of their hypertensive condition.
Stage 2 RCT: Evaluate if the intervention increased the proportion of participants who sought further medical attention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Participants in this group received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition. |
|
| Control | No Intervention | Participants in this group did not received a WhatsApp message reminding them to seek further medical attention for their measurement indicated hypertensive condition. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| WhatsApp message | Behavioral | The experimentally evaluated part of the intervention is a WhatsApp message. The message translated from Arabic to English appears below. "Dear [First name], Your BP reading during Beirut Marathon was [reading]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team" |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported seeking of further medical attention. | If participants tell the researcher that they sought further medical attention via a phone call they received approximately 1 month after the WhatsApp messages were sent to participants. | Response taken 56 days after the opportunistic screening (1 = Yes-sought further medical attention, 0 = No) |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported Hypertension | Whether participant says in a pre-intervention survey that they are experiencing hypertension | A survey response taken at the opportunistic screening.(1 = Yes-experiencing hypertension, 0 = No) |
| Self-reported Diabetes |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate | Objectively measured at screening event | An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor |
| year of birth | Year indicated in pre-intervention survey |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fadi Makki, PhD | B4Development Foundation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nudge Lebanon. 3rd Floor, GS Building, Sit Nasab Street | Beirut | Lebanon |
The research team will cannot make identifiable individual participant data available.
The de-identified participant data used in this papers analyses can be made available by contacting Kelly Ann Schmidtke (ORCID identifier: 0000-0001-5993-0358) and can be reused for further analyses.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D015438 | Health Behavior |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
The researchers who called participants to ask if they sought further medical attention was not made aware of the participants' conditions.
|
Whether participant says in a pre-intervention survey that they are experiencing diabetes
| A survey response taken at the opportunistic screening.(1 = Yes-experiencing diabetes, 0 = No) |
| Self-reported High Cholesterol | Whether participant says in a pre-intervention survey that they are experiencing high cholesterol. | A survey response taken at the opportunistic screening.(1 = Yes-experiencing high cholesterol, 0 = No) |
| Systolic blood pressure (SBP) | Objectively measured at screening event | An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor |
| Diastolic blood pressure (DBP) | Objectively measured at screening event | An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor |
| A survey response taken at the opportunistic screening. |
| Height in cm | Height indicated in pre-intervention survey | A survey response taken at the opportunistic screening. |
| Weight in kg | Weight indicated in pre-intervention survey | A survey response taken at the opportunistic screening. |
| Known family history of hypertension | Knowledge of family history indicated in pre-intervention survey | A survey response taken at the opportunistic screening. |
| Know that high blood pressure could cause health problems | Knowledge of blood pressure health problems indicated in pre-intervention survey | A survey response taken at the opportunistic screening. |
| knew that SBP measures over 140 mm Hg and DBP measures over 90mmHg (millimeters of mercury) were the diagnostic thresholds for stage II hypertension that may require treatment | Knowledge of diagnostic thresholds indicated in pre-intervention survey | A survey response taken at the opportunistic screening. |
| Self-reported blood pressure checking | Self-reported blood pressure checking | A survey response taken at the opportunistic screening. (1 = Yes-blood pressure checking, 0 = No) |
| Self-reported cholesterol checking | Self-reported cholesterol checking | A survey response taken at the opportunistic screening. (1 = Yes-cholesterol checking, 0 = No) |
| Self-reported diabetes checking | Self-reported diabetes checking | A survey response taken at the opportunistic screening.(1 = Yes-diabetes checking, 0 = No) |
| Self-reported attends regular physical check-ups | Self-reported attends regular physical check-ups | A survey response taken at the opportunistic screening.(1 = Yes-attends regular checkups, 0 = No) |
| Self-reported uses alcohol | Self-reported uses alcohol | A survey response taken at the opportunistic screening.(1 = Yes-consumes alcohol, 0 = No) |
| Self-reported smoking | Self-reported smoking | A survey response taken at the opportunistic screening.(1 = Yes-smokes, 0 = No) |